106 related articles for article (PubMed ID: 21903943)
1. Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general population.
Stender S; Frikke-Schmidt R; Anestis A; Kardassis D; Sethi AA; Nordestgaard BG; Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2990-6. PubMed ID: 21903943
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
[TBL] [Abstract][Full Text] [Related]
3. Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease.
Stene MC; Frikke-Schmidt R; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2008 Jul; 52(5):369-77. PubMed ID: 18652945
[TBL] [Abstract][Full Text] [Related]
4. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease.
Schou J; Frikke-Schmidt R; Kardassis D; Thymiakou E; Nordestgaard BG; Jensen G; Grande P; Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):506-15. PubMed ID: 22155456
[TBL] [Abstract][Full Text] [Related]
6. Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
Hornstrup LS; Tybjærg-Hansen A; Haase CL; Nordestgaard BG; Sillesen H; Grande P; Frikke-Schmidt R
Circ Cardiovasc Genet; 2011 Oct; 4(5):534-41. PubMed ID: 21831958
[TBL] [Abstract][Full Text] [Related]
7. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
Haase CL; Tybjærg-Hansen A; Grande P; Frikke-Schmidt R
J Clin Endocrinol Metab; 2010 Dec; 95(12):E500-10. PubMed ID: 20826588
[TBL] [Abstract][Full Text] [Related]
8. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
9. Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.
Bergholdt HK; Nordestgaard BG; Varbo A; Ellervik C
Int J Epidemiol; 2015 Apr; 44(2):587-603. PubMed ID: 26085675
[TBL] [Abstract][Full Text] [Related]
10. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
Freiberg JJ; Tybjaerg-Hansen A; Sillesen H; Jensen GB; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):990-6. PubMed ID: 18276912
[TBL] [Abstract][Full Text] [Related]
11. Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.
Stene MC; Frikke-Schmidt R; Nordestgaard BG; Steffensen R; Schnohr P; Tybjaerg-Hansen A
Atherosclerosis; 2006 Sep; 188(1):43-50. PubMed ID: 16289551
[TBL] [Abstract][Full Text] [Related]
12. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
13. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
[TBL] [Abstract][Full Text] [Related]
14. Genetically elevated C-reactive protein and ischemic vascular disease.
Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
N Engl J Med; 2008 Oct; 359(18):1897-908. PubMed ID: 18971492
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.
Johannsen TH; Kamstrup PR; Andersen RV; Jensen GB; Sillesen H; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Endocrinol Metab; 2009 Apr; 94(4):1264-73. PubMed ID: 19088157
[TBL] [Abstract][Full Text] [Related]
16. Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.
Johannsen TH; Frikke-Schmidt R; Schou J; Nordestgaard BG; Tybjærg-Hansen A
J Am Coll Cardiol; 2012 Nov; 60(20):2041-8. PubMed ID: 23083790
[TBL] [Abstract][Full Text] [Related]
17. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.
Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in ABCA1 predicts ischemic heart disease in the general population.
Frikke-Schmidt R; Nordestgaard BG; Jensen GB; Steffensen R; Tybjaerg-Hansen A
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):180-6. PubMed ID: 17951323
[TBL] [Abstract][Full Text] [Related]
20. Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Hornstrup LS; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1441-7. PubMed ID: 23580146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
